Merck KGaA revives testing of lung cancer vaccine – Fox News

by lowes1 on September 25, 2013


Economic Times
Merck KGaA revives testing of lung cancer vaccine
Fox News
German drugmaker Merck KGaA will conduct new tests on an experimental lung cancer vaccine which failed a previous late-stage clinical trial, it said on Wednesday. Merck said it would test the drug formerly known as Stimuvax and now called tecemotide on 
Oncothyreon-Merck Serono lung cancer drug testing to continuePuget Sound Business Journal (Seattle) (blog)
Merck Serono to Continue Development of Oncothyreon Lung Cancer Drug4-traders (press release)
Merck KGaA to Continue Developing Tecemotide for Lung CancerDrug Discovery & Development
Medical Daily -Economic Times -Fort Worth Star Telegram
all 16 news articles »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: